August 2014 – CROss Research has received a positive Establishment Inspection Report from FDA
that closes a 5-days High Priority Pre-Validation Data inspection conducted at CROSS Research Phase I unit in May 2014.
that closes a 5-days High Priority Pre-Validation Data inspection conducted at CROSS Research Phase I unit in May 2014.
No FDA form 483, Inspectional Observations, was issued.
CROSS Research is glad to have helped our study Sponsor in the on-going US registration process of one of its top products. This flawless result confirms the high quality of CROSS Research services and full acceptance of our standards by the US Regulatory Authorities.